Home > News

Latest News

20/07/2023

The little pill that promotes weight loss, no drugs needed

01/06/2023

A randomized controlled pivotal study of a biodegradable device for weight loss: Study design and rationale

02/03/2023

Epitomee and Nestlé Health Science Announced Completion of Patient Enrollment in Epitomee’s Weight Loss Capsule Pivotal Study (United States)

17/11/2022

Study shows less snacking and reduced meal size, when using Epitomee’s novel weight management aid

15/05/2022

Epitomee Medical Appoints Safi Landskroner as VP of Business Development

13/03/2022

Epitomee Is Scaling Up for Mass Production of Weight Management Platform

15/12/2021

Epitomee Medical Completes a $51M IPO With a Pre-Money Valuation of $200M

01/09/2020

Epitomee Receives CE Mark for Weight management and Weight Loss Treatment

14/08/2020

Israeli Biomed Epitomee partners with Nestle to market globally coveted weight loss solution

11/08/2020

Nestlé Health Science and Epitomee Medical Ltd. enter into an agreement to develop and commercialize a novel weight loss and metabolic health product

25/06/2019

Safety, tolerability and efficacy of a novel self‐use biodegradable device for management of obesity

10/04/2019

Weight loss capsule co Epitomee raises $8m

23/10/2018

First Clinical Results of the Epitomee Capsule

30/07/2018

The Epitomee Solution for Weight Loss and Body Circumference Reduction Presented at the IsraeLIVE Endoscopy International 2018 Conference

29/05/2018

Epitomee Capsule Concept Presented at the Mixii Biomed